NIFUROKSAZYD HASCO 200 mg (Nifuroxazide)

NIFUROKSAZYD HASCO 200 mg (Nifuroxazide)
Product Description

Type: Drug
Pharmaceutical form: Tablets
Package: 12 tablets

Active principle:
Each tablet contains 200 mg of Nifuroxazide

Indications:
Acute or chronic diarrhea in bacterial infections of the gastrointestinal tract.

Contraindications:  
Hypersensitivity to Nifuroxazide, 5-nitrofuran derivatives or any of the excipients.

Read more Show less

Hasco-Lek S.A.

  • PL
  • 2015
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Generics/Biosimilars Manufacturer
Licensee
Primary activities
Pharmaceutical Company (generic finished products)
View company profile

Hasco-Lek S.A.

  • PL
  • 2015
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Generics/Biosimilars Manufacturer
Licensee
Primary activities
Pharmaceutical Company (generic finished products)
View company profile

More Products from Hasco-Lek S.A. (99)

show all 99 other products

Hasco-Lek S.A. resources (1)

  • Hasco-Lek License-out List

    Brochure Hasco-Lek License-out List

    HASCO-LEK is a generic production pharmaceutical company located in Poland offering CTD Dossiers (OTC, Rx) and Medical Devices under License & Supply or Distribution agreements and Contract Manufacturing with Technology Transfer or Development options for Pharmaceutical Products and Food Supplements.